The European Medicine Agency (EMA) is working on the digitalisation of regulatory processes for medicines with the aim of facilitating...
The use of food supplements in Italy is increasingly widespread, but at the same time the presence on the market...
Di Renzo Regulatory Affairs has become a member of Unindustria, a regional association that is part of the system of...
It is a lesson from great masters that the more you know a subject the easier you will be able...
What are orphan drugs? Why are they important? Is there any incentive for their development? Orphan drugs are medicines developed...
The Quality Management System (QMS) is a control system, i.e. a set of activities aimed at verifying that the outcomes...
The so-called “Bills Decree” (“Decreto Bollette” – Law-Decree 30 March 2023, no. 34 “Urgent measures to support families and enterprises...
The sector of Artificial Intelligence (AI) is continuously evolving, and in the next few years the impact of this new...
On 20 March 2023, Regulation (EU) 2023/607 of the European Parliament and of the Council of 15 March 2023 was...
